Web Analytics

3 Latest Announced Rounds

  • $5,300,000
    Seed

    4 Investors

    Software Development
    Oct 24th, 2025
  • $20,000,000
    Series A

    1 Investors

    Financial Services
    Oct 24th, 2025
  • $38,500,000
    Seed

    4 Investors

    Technology, Information and Internet
    Oct 24th, 2025
$822.16M Raised in 50 Funding Rounds in the past 7 Days - View All

Funding Round Profile

BioLoomics, Inc.

start up
United States - Boulder, CO
  • 20/09/2023
  • Seed
  • $8,700,000

BioLoomics is a preclinical stage biotechnology company leveraging directed evolution of antibodies in human cells to create target degrading antibodies. Our proprietary tech combines single-cell bioassay engineering, robotics, and ML.
#synbio #directedevolution #antibodies


Related People

Doug ChapnickFounder

Doug Chapnick United States - Boulder, Colorado

Entrepreneur and biotechnology developer.